4-Choroo-2-Hydroxybenzothiazole

Introduced under trade codes such as HOBT-Cl-4 and similar alphanumeric designators reflecting the substitution pattern, 4-chloro-2-hydroxybenzothiazole (CAS 39207-91-3, molecular formula C₇H₄ClNOS, relative molecular mass 185.63 g·mol⁻¹) exists as a pale-yellow to off-white crystalline solid at ambient conditions. The product is routinely supplied in technical grade (98.0% minimum purity by HPLC, area normalization) and high-purity grade (99.5% minimum) for pharmaceutical intermediate synthesis. The heterocyclic backbone combines a benzothiazole nucleus with a hydroxyl substituent at the 2-position and an aromatic chlorine atom at the 4-position, yielding a hydrogen-bond donor-acceptor profile that governs its solubility in polar aprotic solvents (DMF, NMP, DMSO) and limited solubility in water (<0.5 g·L⁻¹ at 25°C, unbuffered). Manufacturing routes typically proceed via cyclocondensation of 2-amino-4-chlorophenol with carbon disulfide under alkaline conditions, followed by acidification and recrystallization from toluene-methanol mixtures. The resulting crystal habit—platelets of 10–50 μm median particle size when milled under a pin-disc system—affects dissolution kinetics in downstream amidification and etherification steps. Producers ship the anhydrous material in 25 kg net fibre drums with PE inner liners; storage stability exceeds 24 months at ≤25°C and ≤60% relative humidity, provided the package remains sealed.

What Differentiates 4-Chloro-2-Hydroxybenzothiazole from Mercapto- and Amino-Benzothiazoles in Crosslinking Chemistry?

The displacement of the 2-mercapto group found in 2-mercaptobenzothiazole (MBT) with a hydroxyl moiety markedly alters the compound’s role in accelerated sulfur vulcanization. While MBT and its sulfenamide derivatives (CBS, TBBS) act as direct accelerators by generating zinc-thiolate complexes that activate elemental sulfur, 4-chloro-2-hydroxybenzothiazole is not employed as a standalone accelerator. Instead, it serves as a versatile precursor to a class of delayed-action accelerators where the hydroxyl group is converted to a sulfenamide or thiocarbamate function. Conversion with primary amines in the presence of sulfur monochloride yields N-substituted 4-chloro-2-benzothiazole sulfenamides, which exhibit scorch times (ts₂ at 135°C) exceeding 8–12 min when tested per ASTM D5289-19a (MDR 2000 rheometer, 0.5° arc). By contrast, standard MBT-accelerated natural rubber compounds typically record scorch times of 2–4 min under identical conditions. The electron‑withdrawing chlorine at the 4‑position further moderates cure rate by reducing electron density on the thiazole ring, raising the activation energy for accelerator decomposition. Vulcanization kinetic parameters derived from oscillating disc rheometer data show a cure rate index (CRI) reduction of 30–45% relative to unsubstituted 2-mercaptobenzothiazole, making the chloro‑hydroxy precursor attractive for thick‑section industrial rubber goods where premature crosslinking during processing is a recurrent failure mode on L/D=16 cold‑feed extruders. Published data for this specific derivative in direct vulcanization systems are limited; most industrial applications proceed through the in‑situ generation of the active sulfenamide species.

Physical Specifications and Batch‑to‑Batch Consistency Metrics

The following table collates standard release criteria anchored to recognized test methods, enabling verification across procurement lots destined for cGMP intermediate synthesis and technical rubber chemical manufacturing.

Process‑induced variability in crystal morphology can alter bulk density (0.45–0.55 g·cm⁻³ tapped) and flow properties. Air‑micronized material with a d₉₀ of 15 μm is specified for suspension concentrate formulations requiring long‑term physical stability without sediment compaction. Pre‑drying in a vacuum tray dryer at 60°C and ≤10 mbar for 4 h is mandatory when the moisture content exceeds 0.5% upon receipt; failure to do so leads to hydrolysis of downstream sulfenamide products and a 15–20°C depression in the melting point of the isolated intermediate. The compound is incompatible with strong bases—aqueous sodium hydroxide above 1 M induces ring‑opening and generation of 2‑amino‑4‑chlorothiophenol, detectable by a distinct mercaptan odor. Thermal gravimetric analysis (TGA) at 10°C·min⁻¹ under nitrogen flow reveals the onset of mass loss at approximately 180°C, accelerating above 220°C with HCl evolution; thus, reactors for derivatisation should be designed with Hastelloy C‑22 condensers and alkali scrubber capacity.

A second table integrates European regulatory compliance positions, which frequently govern formulation and transboundary shipment decisions for specialty chemical intermediates derived from this benzothiazole.

When the 4-Chloro Substituent Enables Nucleophilic Aromatic Substitution Routes to Pharmaceutical Building Blocks

Synthetic sequences targeting 4‑substituted benzothiazole pharmacophores exploit the lability of the aromatic chlorine atom under nucleophilic attack. In polar, high‑boiling solvents such as N‑methyl‑2‑pyrrolidone (NMP) at 120–140°C, the 4‑chloro position undergoes ipso‑substitution with primary and secondary aliphatic amines—piperidine, morpholine, and N‑Boc‑piperazine—to generate derivatives used as kinase inhibitor intermediates. Reaction progress is monitored by quenching aliquots into dilute HCl and extracting with ethyl acetate; TLC (silica gel 60 F254, hexane:EtOAc 3:1) tracks the disappearance of the starting material at Rf 0.55. Extended heating beyond 48 h yields a bis‑adduct impurity where the 2‑hydroxyl group engages in Ullmann‑type coupling, a side‑reaction suppressed by switching to a tertiary amine base with no N–H bonds, such as DIPEA at 2.0 eq. The electron‑withdrawing effect of the thiazole ring renders the 4‑position roughly 10³ times more reactive toward amines than the 2‑chloro analog, 2,4‑dichlorobenzothiazole, a derivative that introduces cross‑reactivity with the 2‑position unless carefully temperature‑controlled.

In fine chemical production environments, an agitated glass‑lined reactor of 2000 L capacity, equipped with a split‑tube glass condenser and a temperature‑controlled heating jacket circulating pressurised water, is charged with 150 kg of 4‑chloro‑2‑hydroxybenzothiazole, 320 L anhydrous NMP, and the amine nucleophile in slight excess (1.05 eq). The headspace is blanketed with nitrogen at 0.2 bar positive pressure throughout the reaction period. At completion, the batch is quenched into 1500 L deionised water at 5–10°C, precipitating the product, which is isolated via a pressure nutsche filter and washed with cold isopropanol. The damp cake undergoes recrystallization from a 3:1 toluene‑isopropanol mixture, yielding a target purity exceeding 99.0% by HPLC. Differential scanning calorimetry (DSC) of the dried intermediate typically exhibits a sharp endothermic melt at 178–182°C (ΔH ∼95 J·g⁻¹), with no decomposition exotherm below 250°C. The use of a Hastelloy‑lined dryer is recommended when the recrystallization solvent retains even traces of hydrogen chloride, as stainless steel 316L surfaces are prone to pitting corrosion under these conditions.

The application of 4-chloro-2-hydroxybenzothiazole as a building block extends to thioether formation when treated with sodium hydrosulfide in DMF at 80°C, generating a mercapto intermediate that is alkylated in situ to produce 4‑alkylthio derivatives with logP values shifted upward by approximately 1.2–1.8 units compared to the 4‑chloro precursor, as estimated by shake‑flask OECD TG 107 methodology. These sulfur‑bridged analogues display potent activity in high‑throughput screening campaigns targeting bacterial DNA gyrase; published IC₅₀ values against Staphylococcus aureus gyrase fall in the 200–500 nM range for select analogs, though the parent compound itself shows no significant enzyme inhibition. Critically, the 4‑chloro handle is orthogonal to the 2‑hydroxy group, permitting sequential functionalization without protective group strategies, a molecular feature that separates it from 2‑amino‑4‑chlorobenzothiazole, where both positions require differentiation through acyl protection.

Microbicide Performance and Compatibility Boundaries in Recirculating Aqueous Systems

The compound’s role in industrial water treatment is distinct from the fast‑kill profile associated with 5‑chloro‑2‑methyl‑4‑isothiazolin‑3‑one (CMIT) and its blends with MIT. Where isothiazolinones achieve a log‑4 reduction in viable cell counts within 30 min at 5–15 ppm active concentration, benzothiazole‑based microbicides like 4‑chloro‑2‑hydroxybenzothiazole—frequently formulated as its water‑soluble sodium salt hydrate—exhibit a slower kill kinetic that translates to extended preservation of metalworking fluid sumps. Efficacy testing per ASTM E2315 (time‑kill suspension test) against Pseudomonas aeruginosa ATCC 15442 yields a >3‑log reduction at 500 ppm active after 24 h contact time, but only 1.5‑log at 100 ppm over the same interval. This moderate activity is deliberately leveraged in formulations where maintenance of a persistent low‑level biostatic concentration (50–200 ppm) suffices to suppress biofilm development on heat exchanger surfaces, without the rapid consumption observed for more electrophilic biocides that react with tramp lubricating oils.

Compatibility with common coolant additives is a governing factor in formulation design. The sodium salt of 4‑chloro‑2‑hydroxybenzothiazole remains soluble in hard water containing 500 ppm CaCO₃ without precipitation, and it is stable for 28 days at pH 8.5–9.5 and 40°C, based on accelerated stability testing per OECD GD 111. However, the presence of quaternary ammonium‑based cationic corrosion inhibitors at concentrations exceeding 100 ppm triggers flocculation through charge neutralization; this incompatibility does not arise with 2‑mercaptobenzothiazole‑based corrosion inhibitors, which remain monomeric under identical conditions. Field experience from automotive engine plant central systems (twin‑belt filtration, sump volume 40 m³) demonstrates that maintaining 150–200 ppm of the benzothiazole actives in the aqueous phase, confirmed by UV absorbance at 315 nm, suppresses fungal growth on acrylic sight glasses and reduces the frequency of dump‑and‑clean cycles from 8 weeks to beyond 16 weeks. Despite these performance data, the compound is not classified as a biocide active substance under EU BPR (528/2012) in most jurisdictions, and formulators must independently validate regulatory compliance for end‑use claims.